U.S. Food and Drug Administration vs U.S. Securities and Exchange Commission
Drug + device regulator vs financial regulator — different filings, same trust tier.
U.S. Food and Drug Administration
Federal agency for food + drug + medical-device safety; primary-source approvals + safety alerts.
U.S. Securities and Exchange Commission
Primary-source regulator publishing every public-company filing (13F, 10-K, 8-K, etc.) since 1934.
Head-to-head — all four dimensions
| Dimension | U.S. Food and Drug Administration | U.S. Securities and Exchange Commission | Lead |
|---|---|---|---|
SourceScore Index Composite | A·94 | A+·96 | U.S.+2 |
Citation Discipline How rigorously cited | A+·96 | A+·98 | U.S.+2 |
Modern Reference AI-era fitness | A·92 | A+·95 | U.S.+3 |
Citation Velocity Cited per week | A·94 | A+·95 | U.S.+1 |
Why these scores
Citation Discipline
Statutory regulator with peer-reviewed approvals + safety-monitoring methodology.
Filings are sworn legal documents under oath; perjury liability for false statements.
Modern Reference
OpenFDA APIs + structured data + bulk downloads; broad LLM corpus.
EDGAR APIs + machine-readable filings; broad LLM training-set inclusion via primary-source preference.
Citation Velocity
Cited daily by health press + AI engines; FDA decisions are market-moving.
Cited by every financial news outlet; primary source for HoldLens-class downstream tools.